Using the rate of positive high-Risk HPV test results for ASC-US together with the ASC-US/SIL ratio in evaluating the performance of cytopathologists

American Journal of Clinical Pathology

Volumn 129, Issue 1, 2008, Pages 97-101

  Cibas, Edmund S ^a,b   Zou, Kelly H ^b,c   Crum, Christopher P ^a,b   Kuo, Frank ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Atypical squamous cells; Cervical cancer; Cytology; Human papillomavirus; Papanicolaou test; Quality control

Indexed keywords

ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; LABORATORY DIAGNOSIS; PAPANICOLAOU TEST; PATHOLOGIST; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SQUAMOUS INTRAEPITHELIAL LESION; WART VIRUS; ARTICLE; FEMALE; HEALTH CARE DELIVERY; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; STANDARD; TASK PERFORMANCE; UNITED STATES; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; MASSACHUSETTS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; QUALITY CONTROL; TASK PERFORMANCE AND ANALYSIS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 38449114779     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/KXV1MA3L9HMQU7HY     Document Type: Review

References (14)

1. Kohn LT, Corrigan J, Donaldson MS, and the Institute of Medicine Committee on Quality of Health Care in America. To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2000.
2. The Joint Commission. Performance measurement. Available at http://www.jointcommission.org/PerformanceMeasurement/. Accessed May 22, 2007.
3. Jones BA, Novis DA. Nongynecologic cytology turnaround time: a College of American Pathologists Q-Probes study of 180 laboratories. Arch Pathol Lab Med. 2001;125:1279-1284.
4. Renshaw AA, Dean BR, Cibas ES. Receiver operating characteristic curves for analysis of the results of cervicovaginal smears: a useful quality improvement tool. Arch Pathol Lab Med. 1997;121:968-975.
5. Juskevicius R, Zou KH, Cibas ES. An analysis of factors that influence the ASCUS/SIL ratio of pathologists. Am J Clin Pathol. 2001;116:331-335.
6. Nascimento A F, Cibas ES. The ASC/SIL ratio of cytopathologists as a quality control measure: a follow-up study. Am J Clin Pathol. 2007;128:653-656.
7. Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 2nd ed. New York, NY: Springer; 2004.
8. Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
9. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol. 1994;102:182-187.
10. Stoler MH. ASC, TBS, and the power of ALTS. Am J Clin Pathol. 2007;127:489-491.
11. Chhieng DC, Chen J, Connolly K, et al. High-risk HPV DNA detection rate in patients with atypical squamous cells and its relationship to the atypical squamous cell: squamous intraepithelial lesion ratio. Acta Cytol. 2006;50:291-294.
12. Zuna RE, Moore W, Dunn ST. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor. Mod Pathol. 2001;14:147-151.
13. Ko V, Nanji S, Tambouret R, et al. Testing for HPV as an objective measure for quality assurance in gynecologic cytology: positive rates in equivocal and abnormal specimens and comparison with the ASCUS to SIL ratio. Cancer. 2007;111:67-73.
14. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.